Sign In
Buy KMT
$32.67
-0.89 (-2.65%)
At Close: Jun 03, 2026
Kennametal (KMT) Beats Q3 Earnings and Revenue Estimates
08:45am, Wednesday, 06'th May 2026
Kennametal (KMT) came out with quarterly earnings of $0.77 per share, beating the Zacks Consensus Estimate of $0.68 per share. This compares to earnings of $0.47 per share a year ago.
Kennametal Announces Fiscal 2026 Third Quarter Results
06:30am, Wednesday, 06'th May 2026
Sales of $593 million increased 22 percent and 19 percent on a reported and organic basis, respectively Operating income of $79 million and adjusted operating income of $82 million, up 80 percent and
Here's What to Note Ahead of Howmet Aerospace's Q1 Earnings Release
01:55pm, Tuesday, 05'th May 2026
HWM heads into Q1 earnings with strong aerospace demand expected to drive growth, though supply-chain issues and transport softness linger.
Here's Why Kennametal (KMT) is a Strong Momentum Stock
10:51am, Monday, 04'th May 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Kennametal (KMT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:01am, Wednesday, 29'th Apr 2026
Kennametal (KMT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Looking for Earnings Beat? Buy These 4 Top-Ranked Stocks
10:06am, Monday, 27'th Apr 2026
Top-ranked stocks Kennametal (KMT), Reddit Inc. (RDDT), Valero Energy (VLO) and PIPER SANDLR CP (PIPR) are likely to beat on the bottom line in their upcoming releases.
4 Stocks With Impressive Interest Coverage Ratios to Buy Now
11:25am, Thursday, 23'rd Apr 2026
KMT, TPR, RL and CLS post impressive interest coverage ratios, signaling a stronger ability to meet debt interest from operating earnings.
Actimab-A combinations enhanced in vivo AML cell killing across multiple preclinical models, independent of mutation status, when combined with standard-of-care targeted and non-targeted therapies inc
Will Kennametal (KMT) Beat Estimates Again in Its Next Earnings Report?
01:10pm, Tuesday, 21'st Apr 2026
Kennametal (KMT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Are Industrial Products Stocks Lagging Kennametal (KMT) This Year?
10:41am, Friday, 17'th Apr 2026
Here is how Kennametal (KMT) and Karat Packing (KRT) have performed compared to their sector so far this year.
Why Kennametal (KMT) Might be Well Poised for a Surge
01:20pm, Thursday, 16'th Apr 2026
Kennametal (KMT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Kennametal (KMT) Upgraded to Strong Buy: What Does It Mean for the Stock?
01:01pm, Wednesday, 15'th Apr 2026
Kennametal (KMT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Kennametal to Host Earnings Conference Call & Webcast on Third Quarter Fiscal 2026 Results
06:30am, Wednesday, 15'th Apr 2026
PITTSBURGH, April 15, 2026 /PRNewswire/ -- Kennametal Inc. (NYSE: KMT) will host its third quarter fiscal year 2026 earnings call on Wednesday, May 6, 2026. The press release and presentation will be
Why Kennametal (KMT) is a Top Value Stock for the Long-Term
10:40am, Tuesday, 14'th Apr 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Is Kennametal (KMT) a Solid Growth Stock? 3 Reasons to Think "Yes"
01:45pm, Monday, 13'th Apr 2026
Kennametal (KMT) is well positioned to outperform the market, as it exhibits above-average growth in financials.
